Trades on 2 secondary markets

Sidewinder Therapeutics

Sidewinder Therapeutics is a clinical-stage biopharmaceutical company founded in 2023 and headquartered in San Diego, developing a new generation of precision bispecific antibody-drug conjugates (ADCs) for the treatment of solid tumors. Its engineered biologics bind two complexed targets simultaneou

emerging 15.0 / 100 0 APIs View provider profile →

Company Biotechnology Biopharmaceutical Oncology Antibody-Drug Conjugates Cancer Therapeutics

Sidewinder Therapeutics is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.

Where It Trades

EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.